History | Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal) | Guidance | NICE

History

Invitation to participate

Final scope (PDF 217 KB)

Published:

28 March 2018
Final matrix (PDF 299 KB)

Published:

28 March 2018
Equality impact assessment (Scoping) (PDF 176 KB)

Published:

28 March 2018
NICE's response to comments on the draft scope and provisional matrix (PDF 262 KB)

Published:

28 March 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (PDF 306 KB)

Published:

29 November 2017
Draft matrix post referral (PDF 298 KB)

Published:

29 November 2017